PSA, in combination with morphology-based factors such as clinical stage and biopsy Gleason sum, is used most commonly to diagnose and monitor prostate disease progression, but has limited efficacy due to less than ideal specificity and sensitivity. The gene discussed is KLK3; the disease is prostatitis.